Genomic Profiling of Mitochondrial Disease - Imaging Analysis for Precise Mitochondrial Medicine

CompletedOBSERVATIONAL
Enrollment

9

Participants

Timeline

Start Date

May 1, 2022

Primary Completion Date

January 22, 2024

Study Completion Date

January 22, 2024

Conditions
Mitochondrial MyopathiesMitochondrial DNA MutationMitochondrial DiseasesChronic Progressive External Ophthalmoplegia With MyopathyKearns-Sayre Syndrome
Trial Locations (1)

55901

Mayo Clinic, Rochester

Sponsors

Lead Sponsor

Collaborators (1)

All Listed Sponsors
collaborator

Casimir, LLC

UNKNOWN

collaborator

Astellas Pharma Inc

INDUSTRY

lead

Mayo Clinic

OTHER